pad2 Search Results


90
ATCC pcdna3 1 pad2
Pcdna3 1 Pad2, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pcdna3 1 pad2/product/ATCC
Average 90 stars, based on 1 article reviews
pcdna3 1 pad2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

94
MedChemExpress afm32a
(A) Representative light micrographs of primary myoblasts differentiated for 24 h and immunostained for MHC under control (untreated), DMSO, <t>AFM32A,</t> or GSK484 treatment. Scale bar, 280 μm. (B,C) Representative immunoblots (left) and corresponding quantification (right) of myogenin, MHC, PAD2, PAD3, PAD4, and the histone H3 citrullination mark, H3CitR2+R8+R17, in primary myoblasts differentiated for 24 h in the presence of AFM32A (640 µM; B ) or GSK484 (40 µM; C ). (D) Schematic representation of the in vivo experimental design to assess the effects of PAD inhibition on skeletal muscle regeneration. Cardiotoxin (CTX) was injected into the tibialis anterior (TA) muscle, followed by intraperitoneal administration of AFM32A or GSK484 at 3-, 4-, and 5-days post-injury (dpi), with analysis at 7 dpi in male and female mice. ( E ) Hematoxylin & Eosin (H&E) staining of representative 10 μm cross-sections of contralateral undamaged TA muscle and injured TA at 7 dpi under vehicle control, AFM32A, or GSK484 treatment. (F) Myofiber regeneration was quantified by measuring fiber diameter. Scale bars, 270 μm. (G) Representative PicroSirius Red and Masson’s trichrome staining of 10 μm TA muscle cross-sections from contralateral undamaged and injured muscles under vehicle, AFM32A, or GSK484 treatment. Bar graphs represent mean ± SEM from three independent experiments (N = 3). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
Afm32a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/afm32a/product/MedChemExpress
Average 94 stars, based on 1 article reviews
afm32a - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
Proteintech anti pad2 antibody
(A) Representative light micrographs of primary myoblasts differentiated for 24 h and immunostained for MHC under control (untreated), DMSO, <t>AFM32A,</t> or GSK484 treatment. Scale bar, 280 μm. (B,C) Representative immunoblots (left) and corresponding quantification (right) of myogenin, MHC, PAD2, PAD3, PAD4, and the histone H3 citrullination mark, H3CitR2+R8+R17, in primary myoblasts differentiated for 24 h in the presence of AFM32A (640 µM; B ) or GSK484 (40 µM; C ). (D) Schematic representation of the in vivo experimental design to assess the effects of PAD inhibition on skeletal muscle regeneration. Cardiotoxin (CTX) was injected into the tibialis anterior (TA) muscle, followed by intraperitoneal administration of AFM32A or GSK484 at 3-, 4-, and 5-days post-injury (dpi), with analysis at 7 dpi in male and female mice. ( E ) Hematoxylin & Eosin (H&E) staining of representative 10 μm cross-sections of contralateral undamaged TA muscle and injured TA at 7 dpi under vehicle control, AFM32A, or GSK484 treatment. (F) Myofiber regeneration was quantified by measuring fiber diameter. Scale bars, 270 μm. (G) Representative PicroSirius Red and Masson’s trichrome staining of 10 μm TA muscle cross-sections from contralateral undamaged and injured muscles under vehicle, AFM32A, or GSK484 treatment. Bar graphs represent mean ± SEM from three independent experiments (N = 3). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
Anti Pad2 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti pad2 antibody/product/Proteintech
Average 94 stars, based on 1 article reviews
anti pad2 antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

93
Proteintech anti padi2
(A) Representative light micrographs of primary myoblasts differentiated for 24 h and immunostained for MHC under control (untreated), DMSO, <t>AFM32A,</t> or GSK484 treatment. Scale bar, 280 μm. (B,C) Representative immunoblots (left) and corresponding quantification (right) of myogenin, MHC, PAD2, PAD3, PAD4, and the histone H3 citrullination mark, H3CitR2+R8+R17, in primary myoblasts differentiated for 24 h in the presence of AFM32A (640 µM; B ) or GSK484 (40 µM; C ). (D) Schematic representation of the in vivo experimental design to assess the effects of PAD inhibition on skeletal muscle regeneration. Cardiotoxin (CTX) was injected into the tibialis anterior (TA) muscle, followed by intraperitoneal administration of AFM32A or GSK484 at 3-, 4-, and 5-days post-injury (dpi), with analysis at 7 dpi in male and female mice. ( E ) Hematoxylin & Eosin (H&E) staining of representative 10 μm cross-sections of contralateral undamaged TA muscle and injured TA at 7 dpi under vehicle control, AFM32A, or GSK484 treatment. (F) Myofiber regeneration was quantified by measuring fiber diameter. Scale bars, 270 μm. (G) Representative PicroSirius Red and Masson’s trichrome staining of 10 μm TA muscle cross-sections from contralateral undamaged and injured muscles under vehicle, AFM32A, or GSK484 treatment. Bar graphs represent mean ± SEM from three independent experiments (N = 3). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
Anti Padi2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti padi2/product/Proteintech
Average 93 stars, based on 1 article reviews
anti padi2 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

86
Sino Biological mouse pad2
(A) Representative light micrographs of primary myoblasts differentiated for 24 h and immunostained for MHC under control (untreated), DMSO, <t>AFM32A,</t> or GSK484 treatment. Scale bar, 280 μm. (B,C) Representative immunoblots (left) and corresponding quantification (right) of myogenin, MHC, PAD2, PAD3, PAD4, and the histone H3 citrullination mark, H3CitR2+R8+R17, in primary myoblasts differentiated for 24 h in the presence of AFM32A (640 µM; B ) or GSK484 (40 µM; C ). (D) Schematic representation of the in vivo experimental design to assess the effects of PAD inhibition on skeletal muscle regeneration. Cardiotoxin (CTX) was injected into the tibialis anterior (TA) muscle, followed by intraperitoneal administration of AFM32A or GSK484 at 3-, 4-, and 5-days post-injury (dpi), with analysis at 7 dpi in male and female mice. ( E ) Hematoxylin & Eosin (H&E) staining of representative 10 μm cross-sections of contralateral undamaged TA muscle and injured TA at 7 dpi under vehicle control, AFM32A, or GSK484 treatment. (F) Myofiber regeneration was quantified by measuring fiber diameter. Scale bars, 270 μm. (G) Representative PicroSirius Red and Masson’s trichrome staining of 10 μm TA muscle cross-sections from contralateral undamaged and injured muscles under vehicle, AFM32A, or GSK484 treatment. Bar graphs represent mean ± SEM from three independent experiments (N = 3). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
Mouse Pad2, supplied by Sino Biological, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse pad2/product/Sino Biological
Average 86 stars, based on 1 article reviews
mouse pad2 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

91
Proteintech target padi2
Effect of PgPAD on the onset of joint arthritis. The effect of PgPAD on the onset of arthritis was determined. In this experiment, PgPAD deletion mutant 33277 strain (⊿ pad ) and Pg 33277 wild-type (WT) strain were used, unless Pg W83 strain was specifically described in caption of Figures. ABL of the upper jaw in each group was measured ( a ). Ctrl, PBS inoculation; WT, Pg wild-type inoculation; ⊿ pad , Pg pad knockout strain inoculation. To evaluate inflammation of the gingival tissue 6 weeks after Pg inoculation, IL-6 production in gingival tissue of SKG mice was measured by ELISA ( b ). AS was measured 3 and 6 weeks after Pg inoculation with LA i.p. injection ( c ). To assess CP synthesis, ELISA was performed ( d gingival tissue, e joint tissue, f small intestine, g large intestine). The titer of serum ACPA 6 weeks after Pg inoculation with LA i.p. injection in mice from each group was measured by ELISA ( h ). The production of endogenous <t>PADI2</t> and PADI4 in joint tissue was determined by Western blotting, and then the density of each band was measured by NIH Image-J ( i and j ). Data represent mean ± SD ( b – j ) of 5 mice per group. Statistical analyses were performed using the Tukey-Kramer test and Bonferroni-corrected Mann-Whitney U test for multiple comparisons (* P < 0.05, ** P < 0.01)
Target Padi2, supplied by Proteintech, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/target padi2/product/Proteintech
Average 91 stars, based on 1 article reviews
target padi2 - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

90
ModiQuest recombinant human pad2
Human MDMs (A) and mouse RAW 264.7 (B) macrophages were stimulated with 10 ng/mL LPS in the presence of native or citrullinated LL-37 at the indicated concentrations (0.1–10 μg/mL). Citrullinated LL-37 was obtained by treatment of the native peptide with human <t>PAD2</t> or PAD4 at 23.3 U/mg peptide). The level of TNF-α (A) and NO (B) in the culture supernatants was determined using ELISA or the Griess assay at 6 or 20 h post-stimulation, respectively. Since neither the LL-37 nor the PAD enzymes alone induced the release of NO or TNF-α, for the sake of clarity these controls are not shown in the figure. Data represent the mean ± SD of three independent experiments. ns, not significant; *, p<0.05; **, p<0.01; ***, p<0.001.
Recombinant Human Pad2, supplied by ModiQuest, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human pad2/product/ModiQuest
Average 90 stars, based on 1 article reviews
recombinant human pad2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Thorlabs lp1550-pad2
Human MDMs (A) and mouse RAW 264.7 (B) macrophages were stimulated with 10 ng/mL LPS in the presence of native or citrullinated LL-37 at the indicated concentrations (0.1–10 μg/mL). Citrullinated LL-37 was obtained by treatment of the native peptide with human <t>PAD2</t> or PAD4 at 23.3 U/mg peptide). The level of TNF-α (A) and NO (B) in the culture supernatants was determined using ELISA or the Griess assay at 6 or 20 h post-stimulation, respectively. Since neither the LL-37 nor the PAD enzymes alone induced the release of NO or TNF-α, for the sake of clarity these controls are not shown in the figure. Data represent the mean ± SD of three independent experiments. ns, not significant; *, p<0.05; **, p<0.01; ***, p<0.001.
Lp1550 Pad2, supplied by Thorlabs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lp1550-pad2/product/Thorlabs
Average 90 stars, based on 1 article reviews
lp1550-pad2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
ImmunoReagents inc pad2/pad4
Human MDMs (A) and mouse RAW 264.7 (B) macrophages were stimulated with 10 ng/mL LPS in the presence of native or citrullinated LL-37 at the indicated concentrations (0.1–10 μg/mL). Citrullinated LL-37 was obtained by treatment of the native peptide with human <t>PAD2</t> or PAD4 at 23.3 U/mg peptide). The level of TNF-α (A) and NO (B) in the culture supernatants was determined using ELISA or the Griess assay at 6 or 20 h post-stimulation, respectively. Since neither the LL-37 nor the PAD enzymes alone induced the release of NO or TNF-α, for the sake of clarity these controls are not shown in the figure. Data represent the mean ± SD of three independent experiments. ns, not significant; *, p<0.05; **, p<0.01; ***, p<0.001.
Pad2/Pad4, supplied by ImmunoReagents inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pad2/pad4/product/ImmunoReagents inc
Average 90 stars, based on 1 article reviews
pad2/pad4 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Covance anti-human pad2
Human MDMs (A) and mouse RAW 264.7 (B) macrophages were stimulated with 10 ng/mL LPS in the presence of native or citrullinated LL-37 at the indicated concentrations (0.1–10 μg/mL). Citrullinated LL-37 was obtained by treatment of the native peptide with human <t>PAD2</t> or PAD4 at 23.3 U/mg peptide). The level of TNF-α (A) and NO (B) in the culture supernatants was determined using ELISA or the Griess assay at 6 or 20 h post-stimulation, respectively. Since neither the LL-37 nor the PAD enzymes alone induced the release of NO or TNF-α, for the sake of clarity these controls are not shown in the figure. Data represent the mean ± SD of three independent experiments. ns, not significant; *, p<0.05; **, p<0.01; ***, p<0.001.
Anti Human Pad2, supplied by Covance, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-human pad2/product/Covance
Average 90 stars, based on 1 article reviews
anti-human pad2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Cosmo Bio USA rabbit polyclonal anti-pad2
Human MDMs (A) and mouse RAW 264.7 (B) macrophages were stimulated with 10 ng/mL LPS in the presence of native or citrullinated LL-37 at the indicated concentrations (0.1–10 μg/mL). Citrullinated LL-37 was obtained by treatment of the native peptide with human <t>PAD2</t> or PAD4 at 23.3 U/mg peptide). The level of TNF-α (A) and NO (B) in the culture supernatants was determined using ELISA or the Griess assay at 6 or 20 h post-stimulation, respectively. Since neither the LL-37 nor the PAD enzymes alone induced the release of NO or TNF-α, for the sake of clarity these controls are not shown in the figure. Data represent the mean ± SD of three independent experiments. ns, not significant; *, p<0.05; **, p<0.01; ***, p<0.001.
Rabbit Polyclonal Anti Pad2, supplied by Cosmo Bio USA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal anti-pad2/product/Cosmo Bio USA
Average 90 stars, based on 1 article reviews
rabbit polyclonal anti-pad2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


(A) Representative light micrographs of primary myoblasts differentiated for 24 h and immunostained for MHC under control (untreated), DMSO, AFM32A, or GSK484 treatment. Scale bar, 280 μm. (B,C) Representative immunoblots (left) and corresponding quantification (right) of myogenin, MHC, PAD2, PAD3, PAD4, and the histone H3 citrullination mark, H3CitR2+R8+R17, in primary myoblasts differentiated for 24 h in the presence of AFM32A (640 µM; B ) or GSK484 (40 µM; C ). (D) Schematic representation of the in vivo experimental design to assess the effects of PAD inhibition on skeletal muscle regeneration. Cardiotoxin (CTX) was injected into the tibialis anterior (TA) muscle, followed by intraperitoneal administration of AFM32A or GSK484 at 3-, 4-, and 5-days post-injury (dpi), with analysis at 7 dpi in male and female mice. ( E ) Hematoxylin & Eosin (H&E) staining of representative 10 μm cross-sections of contralateral undamaged TA muscle and injured TA at 7 dpi under vehicle control, AFM32A, or GSK484 treatment. (F) Myofiber regeneration was quantified by measuring fiber diameter. Scale bars, 270 μm. (G) Representative PicroSirius Red and Masson’s trichrome staining of 10 μm TA muscle cross-sections from contralateral undamaged and injured muscles under vehicle, AFM32A, or GSK484 treatment. Bar graphs represent mean ± SEM from three independent experiments (N = 3). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

Journal: bioRxiv

Article Title: Reciprocal regulation between the protein arginine deiminases and mSWI/SNF chromatin remodelers controls skeletal muscle differentiation and regeneration

doi: 10.64898/2026.01.20.700682

Figure Lengend Snippet: (A) Representative light micrographs of primary myoblasts differentiated for 24 h and immunostained for MHC under control (untreated), DMSO, AFM32A, or GSK484 treatment. Scale bar, 280 μm. (B,C) Representative immunoblots (left) and corresponding quantification (right) of myogenin, MHC, PAD2, PAD3, PAD4, and the histone H3 citrullination mark, H3CitR2+R8+R17, in primary myoblasts differentiated for 24 h in the presence of AFM32A (640 µM; B ) or GSK484 (40 µM; C ). (D) Schematic representation of the in vivo experimental design to assess the effects of PAD inhibition on skeletal muscle regeneration. Cardiotoxin (CTX) was injected into the tibialis anterior (TA) muscle, followed by intraperitoneal administration of AFM32A or GSK484 at 3-, 4-, and 5-days post-injury (dpi), with analysis at 7 dpi in male and female mice. ( E ) Hematoxylin & Eosin (H&E) staining of representative 10 μm cross-sections of contralateral undamaged TA muscle and injured TA at 7 dpi under vehicle control, AFM32A, or GSK484 treatment. (F) Myofiber regeneration was quantified by measuring fiber diameter. Scale bars, 270 μm. (G) Representative PicroSirius Red and Masson’s trichrome staining of 10 μm TA muscle cross-sections from contralateral undamaged and injured muscles under vehicle, AFM32A, or GSK484 treatment. Bar graphs represent mean ± SEM from three independent experiments (N = 3). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.

Article Snippet: Primary myoblasts were cultured under differentiation conditions with the pan-PAD enzyme inhibitor BB-Cl amidine (HY-111347; MedChemExpress), the PAD2 inhibitor, AFM32A synthesized as previously described , and the PAD4 inhibitor GSK484 , (SML1658; MilliporeSigma).

Techniques: Control, Western Blot, In Vivo, Inhibition, Injection, Staining, Muscles

Effect of PgPAD on the onset of joint arthritis. The effect of PgPAD on the onset of arthritis was determined. In this experiment, PgPAD deletion mutant 33277 strain (⊿ pad ) and Pg 33277 wild-type (WT) strain were used, unless Pg W83 strain was specifically described in caption of Figures. ABL of the upper jaw in each group was measured ( a ). Ctrl, PBS inoculation; WT, Pg wild-type inoculation; ⊿ pad , Pg pad knockout strain inoculation. To evaluate inflammation of the gingival tissue 6 weeks after Pg inoculation, IL-6 production in gingival tissue of SKG mice was measured by ELISA ( b ). AS was measured 3 and 6 weeks after Pg inoculation with LA i.p. injection ( c ). To assess CP synthesis, ELISA was performed ( d gingival tissue, e joint tissue, f small intestine, g large intestine). The titer of serum ACPA 6 weeks after Pg inoculation with LA i.p. injection in mice from each group was measured by ELISA ( h ). The production of endogenous PADI2 and PADI4 in joint tissue was determined by Western blotting, and then the density of each band was measured by NIH Image-J ( i and j ). Data represent mean ± SD ( b – j ) of 5 mice per group. Statistical analyses were performed using the Tukey-Kramer test and Bonferroni-corrected Mann-Whitney U test for multiple comparisons (* P < 0.05, ** P < 0.01)

Journal: Arthritis Research & Therapy

Article Title: Effect of Porphyromonas gingivalis infection on gut dysbiosis and resultant arthritis exacerbation in mouse model

doi: 10.1186/s13075-020-02348-z

Figure Lengend Snippet: Effect of PgPAD on the onset of joint arthritis. The effect of PgPAD on the onset of arthritis was determined. In this experiment, PgPAD deletion mutant 33277 strain (⊿ pad ) and Pg 33277 wild-type (WT) strain were used, unless Pg W83 strain was specifically described in caption of Figures. ABL of the upper jaw in each group was measured ( a ). Ctrl, PBS inoculation; WT, Pg wild-type inoculation; ⊿ pad , Pg pad knockout strain inoculation. To evaluate inflammation of the gingival tissue 6 weeks after Pg inoculation, IL-6 production in gingival tissue of SKG mice was measured by ELISA ( b ). AS was measured 3 and 6 weeks after Pg inoculation with LA i.p. injection ( c ). To assess CP synthesis, ELISA was performed ( d gingival tissue, e joint tissue, f small intestine, g large intestine). The titer of serum ACPA 6 weeks after Pg inoculation with LA i.p. injection in mice from each group was measured by ELISA ( h ). The production of endogenous PADI2 and PADI4 in joint tissue was determined by Western blotting, and then the density of each band was measured by NIH Image-J ( i and j ). Data represent mean ± SD ( b – j ) of 5 mice per group. Statistical analyses were performed using the Tukey-Kramer test and Bonferroni-corrected Mann-Whitney U test for multiple comparisons (* P < 0.05, ** P < 0.01)

Article Snippet: As a control, the amount of Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was detected by anti-GAPDH antibody (10 μg/ml, HRP-60004, PROTEINTECH JAPAN, Japan) The density of target PADI2 and PADI4 bands was measured by NIH Image-J software.

Techniques: Mutagenesis, Knock-Out, Enzyme-linked Immunosorbent Assay, Injection, Western Blot, MANN-WHITNEY

Human MDMs (A) and mouse RAW 264.7 (B) macrophages were stimulated with 10 ng/mL LPS in the presence of native or citrullinated LL-37 at the indicated concentrations (0.1–10 μg/mL). Citrullinated LL-37 was obtained by treatment of the native peptide with human PAD2 or PAD4 at 23.3 U/mg peptide). The level of TNF-α (A) and NO (B) in the culture supernatants was determined using ELISA or the Griess assay at 6 or 20 h post-stimulation, respectively. Since neither the LL-37 nor the PAD enzymes alone induced the release of NO or TNF-α, for the sake of clarity these controls are not shown in the figure. Data represent the mean ± SD of three independent experiments. ns, not significant; *, p<0.05; **, p<0.01; ***, p<0.001.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Citrullination alters immunomodulatory function of LL-37 essential for prevention of endotoxin-induced sepsis

doi: 10.4049/jimmunol.1303062

Figure Lengend Snippet: Human MDMs (A) and mouse RAW 264.7 (B) macrophages were stimulated with 10 ng/mL LPS in the presence of native or citrullinated LL-37 at the indicated concentrations (0.1–10 μg/mL). Citrullinated LL-37 was obtained by treatment of the native peptide with human PAD2 or PAD4 at 23.3 U/mg peptide). The level of TNF-α (A) and NO (B) in the culture supernatants was determined using ELISA or the Griess assay at 6 or 20 h post-stimulation, respectively. Since neither the LL-37 nor the PAD enzymes alone induced the release of NO or TNF-α, for the sake of clarity these controls are not shown in the figure. Data represent the mean ± SD of three independent experiments. ns, not significant; *, p<0.05; **, p<0.01; ***, p<0.001.

Article Snippet: Recombinant human PAD2 and PAD4 were obtained from Modiquest (The Netherlands).

Techniques: Enzyme-linked Immunosorbent Assay, Griess Assay